Authors
Akash Manes, Joban Sran, Ivjot Samra, Balkaran Dhaliwal, Adam Soliman, Nitasha Puri
Published in
The western journal of emergency medicine. Volume 27. Issue 4. Pages 886-894. Jun 28, 2026. Epub Jun 28, 2026.
Abstract
Hypoventilation and hypercapnia are the primary physiological indicators of opioid-induced respiratory depression (OIRD), while hypoxia is typically a later manifestation. However, use of pulse oximetry to measure oxygen saturation (SpO2) level remains the most widely available and commonly used monitoring modality in both clinical and community settings, whereas capnography is not routinely accessible. Given this reality, it is important to evaluate hypoxia thresholds reported in the literature to inform practical detection and intervention strategies. Oxygen saturation monitoring may serve as a valuable support tool to help determine when individuals experiencing opioid toxicity require intervention; however, there is limited consensus on SpO2 thresholds that indicate OIRD. Our objective in this study was to evaluate existing evidence on SpO2 thresholds for OIRD as a physiological marker to incorporate with clinical assessment to potentially prevent opioid-related outcomes such as hypoxemia, hypoxic brain injury, cardiac arrhythmias, and mortality, and to inform monitoring and intervention strategies for future research.
We electronically searched Ovid MEDLINE, Ovid Embase, PubMed, and grey literature databases for qualitative and quantitative studies published from 2014-2024. We included studies published in English where participants with opioid use disorder (OUD) experienced opioid toxicity and continuous SpO2 monitoring in medical settings. Quality was evaluated using the modified Downs and Black checklist. The primary outcome measure was the SpO2 level used to quantify opioid-induced respiratory depression.
Of the 2,864 articles screened, 37 underwent full-text review, and 16 were included in data extraction and analysis (total patients, N = 12,887). Reported SpO2 thresholds ranged from 85-95% (median 92, interquartile range 90-95). In three studies where patients experienced opioid-induced respiratory depression, SpO2 levels dropped to a median value of 80%.
Although hypoxia is a late indicator of opioid-induced respiratory depression, SpO2 monitoring remains a widely deployed tool for detecting clinically significant deterioration. Reported SpO2 thresholds for defining OIRD ranged from 90-95% across studies of "excellent" and "good" quality, underscoring the need for standardized, patient-centered thresholds to guide monitoring and intervention in future research.
PMID:
42550704
Bibliographic data and abstract were imported from PubMed on 05 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0